A SGLT2 inhibitor dapagliflozin prevents heart failure with preserved ejection fraction through activating mitophagy in ZDF diabetic rats

被引：0
|
作者：
Feng, B. [1 ]
Zhang, N. [2 ]
Shi, B. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Endocrinol & Metab, Suzhou, Peoples R China
[2] Nanjing Med Univ, Affiliated Soochow Hosp, Cardiol, Suzhou, Peoples R China
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
198
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [31] The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
    Steven, Sebastian
    Oelze, Matthias
    Hanf, Alina
    Kroeller-Schoen, Swenja
    Kashani, Fatemeh
    Roohani, Siyer
    Welschof, Philipp
    Kopp, Maximilian
    Goedtel-Armbrust, Ute
    Xia, Ning
    Li, Huige
    Schulz, Eberhard
    Lackner, Karl J.
    Wojnowski, Leszek
    Bottari, Serge P.
    Wenzel, Philip
    Mayoux, Eric
    Muenzel, Thomas
    Daiber, Andreas
    REDOX BIOLOGY, 2017, 13 : 370 - 385
  • [32] The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats
    Hanf, Alina
    Steven, Sebastian
    Oelze, Matthias
    Kroeller-Schoen, Swenja
    Kashani, Fatemeh
    Roohani, Siyer
    Welschof, Philipp
    Kopp, Maximilian
    Goedtel-Armbrust, Ute
    Xia, Ning
    Li, Huige
    Schulz, Eberhard
    Lackner, Karl J.
    Wojnowski, Leszek
    Bottari, Serge P.
    Wenzel, Philip
    Mayoux, Eric
    Muenzel, Thomas
    Daiber, Andreas
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 112 - 113
  • [33] SGLT2 inhibitor dapagliflozin lowers risk of heart failure in diabetes
    Overbeck P.
    MMW - Fortschritte der Medizin, 2018, 160 (20) : 18 - 19
  • [34] SGLT2 inhibition in heart failure with reduced or preserved ejection fraction: Finding the right patients to treat
    Girerd, Nicolas
    Zannad, Faiez
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (05) : 550 - 558
  • [35] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J., V
    Claggett, B.
    de Boer, R. A.
    DeMets, D.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F.
    Shah, S. J.
    Desai, A. S.
    Jhund, P. S.
    Belohlavek, J.
    Chiang, C-E
    Borleffs, C. J. W.
    Comin-Colet, J.
    Dobreanu, D.
    Drozdz, J.
    Fang, J. C.
    Alcocer-Gamba, M. A.
    Al Habeeb, W.
    Han, Y.
    Cabrera Honorio, J. W.
    Janssens, S. P.
    Katova, T.
    Kitakaze, M.
    Merkely, B.
    O'Meara, E.
    Saraiva, J. F. K.
    Tereshchenko, S. N.
    Thierer, J.
    Vaduganathan, M.
    Vardeny, O.
    Verma, S.
    Pham, V. N.
    Wilderang, U.
    Zaozerska, N.
    Bachus, E.
    Lindholm, D.
    Petersson, M.
    Langkilde, A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, : 1089 - 1098
  • [36] Dapagliflozin in Heart Failure with Preserved Ejection Fraction-Reply
    Kjaergaard, Jesper
    Moller, Jacob E.
    Hassager, Christian
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 285 - 286
  • [37] Efficacy of Dapagliflozin in Heart Failure with Preserved Ejection Fraction in the Elderly
    Bu, X. P.
    Li, C. X.
    Li, L.
    Liu, Y. R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S24 - S24
  • [38] SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
    Lu, He
    Shang, Pingping
    Zhou, Dexing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
    Kim, Hyue Mee
    Hwang, In-Chang
    Choi, Wonsuk
    Yoon, Yeonyee E.
    Cho, Goo-Yeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
    Hyue Mee Kim
    In-Chang Hwang
    Wonsuk Choi
    Yeonyee E. Yoon
    Goo-Yeong Cho
    Scientific Reports, 11
12345